multiple testing approaches can provide further support .
Supply chain conundrums
Global supply chain disruptions continue to be significant challenges that affect product development and impact speed to market . Longer delivery times and the difficulties obtaining high-quality raw materials have impacted pharma manufacturing operations . Supply chain costs and operating costs have increased .
Pharmaceutical manufacturers must adapt and innovate to meet the challenge . Seeking partnership with a supplier who can provide technical support , regulatory standards compliance , supply chain transparency and guidance , and a global distribution network , can help mitigate the risk and alleviate problems . Most importantly , suppliers must take steps to ensure quality throughout their own operations to meet the increasing global compliance requirements of pharmaceutical manufacturers .
For example , at Spectrum Chemical all raw materials and finished goods are subject to in-house testing in our cGMP-compliant facilities to ensure that chemicals and ingredients meet stringent quality standards for various locations of multinational drug developers . In addition , documented change controls and sourcing to confirm transparency aid acceleration to market , while ensuring a consistent pipeline of raw materials .
Compliance & quality issues
To be in compliance in manufacturing quality drug products , pharmaceutical companies must comply with all applicable regulations as outlined in the FDA GMP guidelines and cGMP . Major challenges include maintaining quality control and staying current in compliance with changing regulations .
Compliance with FDA regulations and requirements is of the greatest
References : 1 : https :// www . wolterskluwer . com / en / know / pharma Visited January 12 , 2023 . 2 : https :// www . researchandmarkets . com / reports / 5555952 / 2021-pharmaceuticalspre search [ review # src-pos-1 3 : https :// www . iqvia . com / insights / the-iqvia-institute / reports / global-medicinespending-and-usage-trends-outlookto-2025 4 : https :// linchpinseo . com / trendspharmaceutical-industry / 5 : O . Wouters , M . Mckee & J . Luyten , JAMA . 2020 . 323 . 844 . 10.1001 / jama . 2020.1166 . https :// www . researchgate . net / publication / 339670139 _ Estimated _ Research _ and _ Development _ Investment _
importance . Pharmaceutical manufacturers must ensure the quality of their pharmaceutical products . With cGMP guidelines , pharma companies can guarantee the safety and effectiveness of their products that may be manufactured in multiple locations in different countries . This helps to avoid noncompliance with quality standards , product recalls and failures .
Meeting quality standards demands ensuring that every component of a pharmaceutical product is of the highest and purest quality , starting with raw materials and through all ingredients and substances . Another challenge is the difficulty of tracking and maintaining thoroughly detailed records of all production activities , materials used , and manufacturing processes and procedures .
Needed _ to _ Bring _ a _ New _ Medicine _ to _ Market _ 2009-2018 6 : D . Sun , W . Gao , H-X . Hu & S . Zhou , Acta Pharmaceutica Sinica B , July 2022 , ISSN 2211-3835 , https :// doi . org / 10.1016 / j . apsb . 2022.02.002 . ( https :// www . sciencedirect . com / science / article / pii / S2211383522000521 ) 7 : M . Van Etten , PhRMA , June 2021 . https :// catalyst . phrma . org / ip-explainedhow-does-the-u . s . -patent-process-work 8 : M . Mikulic , Statista , October 2022 . https :// www . statista . com / statistics / 309404 / global-total-prescription-drug-revenue-atrisk-from-patent-expiration / 9 : Apple , H . Keane , R . Moss & V . Sartori , McKinsey & Company , July 2019 . https :// www . mckinsey . com / industries / lifesciences / our-insights / designing-an-agiletransformation-in-pharma-r-and-d 10 : Mireku , Pharmaceutical Technology , January 2023 . https :// www . pharmaceuticaltechnology . com / features / can-the-fda-keepthe-momentum-going-for-rare-diseasedrug-approvals / 11 : M . Sardella & G . Belcher , Ther . Adv . Drug Safety . August 2018 , 14 ; 9 ( 11 ): 631-638 . doi : 10.1177 / 2042098618792502 . PMID : 30479738 ; PMCID : PMC6243425 12 : https :// www . ncbi . nlm . nih . gov / pmc / articles / PMC6243425 / 13 : S . Flynn , Eur . Pharm . Review . May 2021 . https :// www . europeanpharmaceuticalreview . com / article / 153871 / six-major-risks-facingpharmaceutical-manufacturers-in-2021 /
Global compliance variations
With both GMP and cGMP , strict attention to regulatory compliance is required . However , around the world how each manufacturer approaches and achieves compliance may have variations , depending on factors such as follow-through on modernising facilities and processes , employee training and leadership decisions on safety , risk and strategies for the best ways to ensure efficiency and business sustainability .
There also can be different interpretations of GMP and cGMP as to what constitutes acceptable levels of quality and effectiveness , especially between mature and new emerging markets ( Figure 2 ). These variations have consequences that impact pharmaceutical discovery , development and
22 SPECIALITY CHEMICALS MAGAZINE ESTABLISHED 1981